SB 6299
Alternative Names: SB-6299Latest Information Update: 02 Feb 2024
At a glance
- Originator Dong-A ST
- Class Antineoplastics
- Mechanism of Action Protein tyrosine phosphatase non-receptor type 6 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer